The Risk of Dying From Extreme Obesity Is Equal to the Risk of Dying From What?

Abstract

Obesity is at present recognized as a chronic or non-catching disease. Contempo inquiry has clarified the physiology of weight regulation, the pathophysiology that leads to unwanted weight proceeds and maintenance of the obese state even when reasonable attempts in lifestyle improvement are made, and the agin wellness consequences of generalized and central obesity. While more than sensitive and specific imaging methods to quantify torso limerick are available, well-nigh office-based practitioners will need measure out only height, weight, and waist circumference. With these, a patient'southward risk for obesity-related co-morbidities such every bit type two diabetes mellitus and cardiovascular disease tin can be estimated and appropriate treatment plans and goals established. Within the Us, prevalence rates for generalized obesity (BMI > 30 kg/one thousand²), extreme obesity (BMI > xl kg/m²), and fundamental obesity are standing to ascent with peak obesity rates occurring in the 5^thursday-7^thdecades. Women take more generalized obesity simply less central obesity than men, and obesity disproportionately affects US minorities. Of business are increases in obesity rates in youth (ages 2-19 years) in the Usa also as around the globe. This trend will likely go on to fuel the global obesity epidemic for decades to come, worsening population health, creating infrastructural challenges as countries effort to encounter the additional health-care demands, and greatly increasing wellness-care expenditures globe-broad. Across individual weight direction, societal and economic innovations will be necessary that focus on strategies to prevent farther increases in overweight and obesity rates. For complete coverage of all related areas of Endocrinology, please visit our on-line FREE spider web-text, WWW.ENDOTEXT.ORG.

INTRODUCTION

Unwanted weight gain leading to overweight and obesity has become a master driver of the global rise in non-communicable diseases and is itself now considered a non-communicable affliction. Because of the psychological and social stigmata that accompany being overweight and obese, those affected by these conditions are also vulnerable to discrimination in their personal and work lives, low self-esteem, and depression. These medical and psychological sequelae of obesity contribute to a major share of current wellness-care expenditures and generate boosted economic costs through loss of worker productivity, increased disability, and premature loss of life.

The recognition that being overweight or obese is a chronic disease and non simply due to poor self-command or a lack of will power comes from the past 70 years of enquiry that has been steadily gaining insight into the physiologythat governs trunk weight (homeostatic mechanisms involved in sensing and adapting to changes in the body'south internal metabolism, environmental food availability, and activity levels then as to maintain torso weight and fat content stability), the pathophysiologythat leads to unwanted weight gain maintenance, and the roles that excess weight and fatty maldistribution play in contributing to chronic diseases such as diabetes, dyslipidemia, eye illness, non-alcoholic fatty liver disease, and many others(ane, two).

As with other chronic diseases, obesity results from an interaction betwixt an individual's genetic predisposition to weight proceeds and ecology influences. Gene discovery in the field of weight regulation and obesity has identified several major single-factor effects resulting in severe and early-onset obesity as well every bit many more minor genes with more variable effects on weight and fatty distribution, including age-of-onset and severity. Even so, currently known major and small genes explain only a small portion of trunk weight variations in the population(3). Several environmental contributors have also been identifiedbut countering these will likely require initiatives that fall far outside of the discussions taking place in the clinician'due south part between patient and provider since they involve making major societal changes regarding food quality, work-related and leisure-fourth dimension activities, and social determinants including disparities in socio-economical status.

Novel discoveries in fields of neuroendocrine and gastrointestinal control of appetite and free energy expenditure have greatly advanced these fields in contempo years. These insights have led to an emerging portfolio of medications that, when added to behavioral and lifestyle improvements, can aid restore appetite control and allow minor weight loss maintenance. They take also led to novel mechanisms that help to explain the superior outcomes (both in terms of meaningful and sustained weight loss likewise as improvements or resolution of co-morbid conditions) following bariatric procedures such as laparoscopic sleeve gastrectomy and gastric bypass(4, 5).

Subsequent capacity in this section of EndoText will delve more deeply into these determinants and scientific advances, providing a greater breadth of information regarding mechanisms, clinical manifestations, handling options, and prevention strategies for those who are overweight or obese (6-12).

DEFINITION OF OVERWEIGHT AND OBESITY

Overweight and obesity occur when excess fat accumulation (regionally, globally, or both) increases risk to health. It is the point at which wellness risk is increased that is most of import considering, equally covered below, body weights and fat distributions that lead to expression of co-morbid diseases occur at dissimilar thresholds depending on the population.

Ideally, an obesity classification system would have the following characteristics: it would exist based on a practical measurement widely available to providers regardless of their setting; information technology would accurately predict wellness risk (prognosis); and it could be used to assign treatment stategies and goals. The most accurate measures of body fat (the major component of body weight responsible for adverse outcomes) such as underwater weighing, dual-free energy x-ray absorptiometry (DEXA) scanning, computed tomograpy (CT), and magnetic resonance imaging (MRI) are impractical for use in everyday clinical encounters. Estimates of trunk fat including body mass alphabetize (BMI, calculated by dividing the body weight in kilograms by tiptop in meters squared, or kg/mⁱⁱ) and waist circumference do have limitations compared to these imaging methods, but still provide relevant information and are easily implemented in a diversity of practice settings.

It is worth pointing out two important caveats regarding thresholds used to diagnose overweight and obesity. The first is that although we favor the assignement of specific BMI cut-offs and increasing risk (Table 1), relationships between trunk weight or fat distribution and conditions that impair health actually stand for a continum. For example, increased adventure for type ii diabetes and premature bloodshed occur well earlier a BMI of xxx kg/chiliadⁱⁱ(the threshold to define obesity in popluations of European extraction) is reached. It is in these before stages that preventative strategies to limit further weight gain and/or allow weight loss will have their greatest health benefits. The second is that historic relationships between increasing weight thresholds weight and co-morbidities are becoming altered as amend treatments for those atmospheric condition become available. For example, in the by several decades, atherosclerotic cardiovascular (ASCVD) mortality has steadily declined in the US population (13)even as obesity rates have risen (see below). Although it is mostly accepted that this turn down in ASCVD deaths is due to improve treatments in the field (better coordination of "first responders" services such equally ambulances and more than widespread use by the public of cardiopulmonary resusitation and defibrillator units), by intensive care units, and in the function (statins, PCSK9 inhibitors, blood pressure medications, stents and other revascularization procedures) (fourteen), these data take also been cited to support of the claim that being overweight might really protect confronting center disease(15). In this regard, updated epidemiological data on the health outcomes related to being overweight or obese should include not just data on morbidity and mortality, but also health intendance utilization and costs, including medications and number of treatment-related procedures performed.

Nomenclature OF OVERWEIGHT, OBESITY, AND Fundamental OBESITY

Fat Mass and Percentage Body Fatty

Every bit mentioned to a higher place, fat mass tin be straight measured past one of several imaging modalities, including DEXA, CT, and MRI, but these systems are impractical and cost prohibitive for general clinical use and, instead, are mostly used for enquiry. Fat mass can be measured indirectly using water (underwater weighing) or air displacement (BODPOD), or bioimpedance analysis (BIA). Each of these methods estimates the proportion of fat or non-fat mass and allows calcutation of percent torso fat. Of these, BODPOD and BIA are often offered through fettle centers and clinics run by obesity medicine specialists. Notwithstanding, their general use in the care of overweight and obese patients is still not recommended. Interpretation of results from these procedures may be confounded by common conditions that accompany obesity, especially when fluid status is altered such as in congenstive heart failure or chronic kidney disease. Also, ranges for normal and aberrant are non well established for these methods and, in practical terms, knowing them will not change electric current recommendations to help patients achieve sustained weight loss.

Body Mass Index

Torso mass index allows comparison of weights independently of stature across populations. Except in persons who have increased lean weight as a event of intense exercise or resistance training (e.k., bodybuilders), BMI correlates well with percentage of body fat, but this relationship is independently influenced by sexual practice, age, and race (16), particularly South Asians in whom evidence suggests that BMI-adjusted pct body fat is greater than other populations (17). In the United states of america, information from the second National Wellness and Nutrition Examination Survey (NHANES II) were used to define obesity in adults as a BMI of 27.3 kg/thou²or more for women and a BMI of 27.8 kg/m²or more than for men(xviii). These definitions were based on the gender-specific 85^thpercentile values of BMI for persons 20 to 29 years of age. In 1998, however, the National Institutes of Health (NIH) Expert Panel on the Identification, Evaluation, and Handling of Overweight and Obesity in Adults adopted the Globe Health Organization (WHO) classification for overweight and obesity (19). The WHO classification, which predominantly applied to people of European ancestry, assigns increasing adventure for comorbid weather—including hypertension, type 2 diabetes mellitus, and cardiovascular disease—to persons with higher a BMI (Table 1) relative to persons of normal weight (BMI of 18.v - 25 kg/1000²). Asian populations, however, are known to be at increased risk for diabetes and hypertension at lower BMI ranges than those for non-Asian groups due to predominance of key fat distribution (see below). Consequently, the WHO has suggested lower cutoff points for consideration of therapeutic intervention in Asians: a BMI of eighteen.5 to 23 kg/m²represents adequate adventure, 23 to 27.v kg/m²confers increased take chances, and 27.5 kg/thou²or higher represents high risk (20).

Table 1

Classification of Overweight and Obesity by BMI, Waist Circumference, and Associated Illness Risk. Adapted from reference (19).

View in own window

	BMI (kg/mii)		Obesity Class	Disease Risk* (Relative to Normal Weight and Waist Circumference)
				Men ≤twoscore inches (≤ 102 cm) Women ≤ 35 inches (≤ 88 cm)	> 40 in (> 102 cm) > 35 in (> 88 cm)
Underweight		< xviii.5		-	-
Normal†		18.5–24.ix		-	-
Overweight		25.0–29.9		Increased	Loftier
Obesity		30.0–34.ix 35.0–39.9	I Ii	High Very High	Very High Very High
Extreme Obesity		≥ 40	III	Extremely Loftier	Extremely High

*Affliction gamble for type 2 diabetes, hypertension, and cardiovascular disease.

†Increased waist circumference can as well be a marker for increased take a chance even in persons of normal weight.

Fatty Distribution (Key Obesity)

In addition to an increase in total body weight, a proportionally greater amount of fat in the abdomen or trunk compared with the hips and lower extremities has been associated with increased risk for blazon 2 diabetes mellitus, hypertension, and heart disease in both men and women (21, 22). Intestinal obesity is commonly reported as a waist-to-hip ratio, but it is most hands quantified past a single circumferential measurement obtained at the level of the superior iliac crest (19). The original US national guidelines categorized men at increased relative chance for co-morbidities such equally diabetes and cardiovascular disease if they have a waist circumference greater than 102 cm (40 inches) and women if their waist circumference exceeds 88 cm (35 inches) (Table 1) (19). Thus, an overweight person with predominantly intestinal fat accumulation would be considered "high" chance for these diseases even if that person is not obese past BMI criteria. These waist circumference thresholds are as well used to define the "metabolic syndrome" by the well-nigh recent guidelines from the American Center Association and the National Lipid Association (23, 24).

However, the relationships betwixt cardinal adiposity with co-morbidities are also a continuum and vary by race and ethnicity. For case, in those of Asian descent, abdominal (primal) obesity has long been recognized to be a ameliorate affliction take chances predictor, peculiarly for type 2 diabetes, than BMI (25). As endorsed past the International Diabetes Federation (26)and summarized in a WHO report in 2008 (27), dissimilar countries and wellness organizations have adopted differing sexual practice- and population-specific cutting off values for waist circumference thresholds predictive of increased risk for weight-related comorbidities. In addition to the US criteria, culling thresholds for central obesity as measured by waist circumference include >94 cm (37 inches) and >80 cm (31.5 inches) for men and women of European anscestry and >ninety cm (35.5 inches) and >80 cm (31.5 inches) for men and women of South Asian, Japanese, and Chinese origin (26, 27).

For the practioner, waist circumference should be measured in a standardized way (19)at each patient's visit forth with torso weight. This measurement can exist used to identify increased risk for diabetes and cardiovascular disease contained of BMI, which in plough is important for the evolution of an individualized weight management arroyo and in motivating patients to attach to recommended lifestyle and medical therapies. Consideration for the utilise of lower waist circumference thresholds than those currently recommended in the Usa should occur when counseling a patient of South and Southeast Asian ancestry or if other components of the metabolic syndrome (e.grand., hypertension, elevated fasting glucose (100 – 125 mg/dL; 5.5 – 6.9 mmol/50), dyslipidemia) or prediabetes (hemoglobin A1c betwixt 5.seven and 6.4%) take been identified.

EPIDEMIOLOGY OF OVERWEIGHT AND OBESITY

In the United States (US), data from the National Health and Nutrition Examination Survey using measured heights and weights shows that the steady increase in the prevalence of obesity in both children and adults over the by several decades has not waned, although there are exceptions among subpopulations equally described in greater item below. In the most recently published US report (2015-2016), 39.8% of adults (BMI ≥ 30 kg/k²) and 18.5% of youth (BMI ≥ 95^thpercentile of age- and sexual practice-specific growth charts) are obese (28)(Figure 1).

Figure 1

Trends in obesity prevalence among adults aged 20 and over (age adjusted) and youth aged 2–19 years: U.s., 1999–2000 through 2015–2016. Youth are anile 2019 years and adults are 20 years and older. Taken from reference (28).

Overweight and Obesity in Adults: Relationships with Age, Sex, and Demographics

On average, these increases stand for a tripling in obesity prevelance rates of the U.s. population since the 1960's (Figure 2). Several trends wtihin this data are worth highlighting. During this time, the prevelance of overweight (BMI ≥ 25 and <30 kg/m²) has remained remarkably stable in both men and women while that of farthermost obesity (BMI ≥ xl kg/m²) has undergone a 9-fold increment from 0.9% in 1960-1962 to eight.1% in 2013-xiv (Figure ii). These large increases in the number of people with obesity and extreme obesity, while at the same fourth dimension the level of overweight has remained steady, suggests that the "obesogenic" environment is disproportionately affecting those portions of the population with the greatest genetic potential for weight proceeds (29, thirty). This currently leaves only ~ 30% of the US population as having a salubrious weight (BMI betwixt xviii.v and 25 kg/m²).

Figure two

Trends in adult overweight, obesity, and extreme obesity among men and women aged 20–74: United States, 1960–1962 through 2013–2014. Overweight is trunk mass index

(BMI) of 25 kg/m2 or greater just less than 30 kg/m2; obesity is BMI greater than or equal to 30; and extreme obesity is BMI greater than or equal to 40. Taken fom (31)

Adult women are, on average, more likely to be obese than men, and the peak rates of obesity for both men and women in the US occur between the ages of xl and threescore years (Figures 2 and 3). In studies that accept measured body composition, fat mass also peaks just past middle age in both men and women, but percent body fatty continues to increase by this age, specially in men because of a proportionally greater loss in lean mass (32-34). The menopausal period has also been associated with an increase in percent body fat and propensity for central fat distribution, even though total body weight may modify very little during this time (35-37).

In general, women and men who did not go to college were similarly more likely to be obese than those who did, but for both groups these relationships varied depending on race and ethnicity (meet beneath). Amongst women, obesity prevelance rates decreased with

increasing income in women (from 45.two% to 29.7%), but there was no departure in obesity prevalence between the everyman (31.5%) and highest (32.six%) income groups among men (38).

Effigy three

Prevalence of obesity amidst adults aged twenty years and over, by sex and historic period: United States, 2015–2016. Taken from reference (28).

Pediatrics

Childhood obesity is a risk factor for adulthood obesity (39, 40). In this regard, the similar tripling of obesity rates in US youth is worrisome. One potential brilliant spot in the nigh recent trends is that obesity prevelance rates of the youngest (ages two-v years) has shown a leveling off since 2005-2006 (Effigy 4 and reference (28)). This may represent societal recognition and reversal of feeding and activeness patterns in this historic period grouping that have previously promoted weight gain and is an opportune historic period group (< 6 years of age) in which to reduce the likelihood for continuing a weight trajectory that leads to developed obesity (41). If this remains truthful, it would yet accept close to a generation before population rates of obesity in adults are affected. Like adults, obesity rates in children are greater when they are live in households with lower incomes and less teaching of the caput of the household (42). In this regard, these obesity gaps have been steadily widening in girls, whereas the differences between boys has been relatively stable (42).

Minorities

The rise in obesity prevalence rates has disproportionately affected US minority populations (28). The highest prevelance rates of obesity by race and ethnicity are currently reported in blacks, native americans, and Hispanics (Figure vand reference (43)). Like in the general population, minority women are more than affected than men, reaching obesity prevelance rates of fifty% and higher for Hispanic and blackness women. The interactions of socieconomic status and obesity rates varied from the general population based on race and ethnicity (38). For example, the expected inverse relationship between obesity and income group did not agree for non-Hispanic black men and women in whom obesity prevelance was actually higher in the highest compared to lowest income group (men) or showed no relationship to income by racial group at all (women) (38). Obesity prevalence was lower amongst college graduates than among persons with less education for non-Hispanic white women and men, black women, and Hispanic women, merely not for black and Hispanic men. Asian men and women have the everyman obesity prevelance rates, which did non vary by eduction or income level (38).

Figure 4

Trends in obesity amongst children and adolescents aged 2–19 years, by age: United States, 1963–1965 through 2013–2014. Obesity is divers as body mass alphabetize (BMI) greater than or equal to the 95th percentile from the sexual practice-specific BMI-for-age 2000 CDC Growth Charts.

An identical pattern of higher obesity rates to those of adult minority groups (Figure 5) are reported in younger minority populations (28). In those age 2-xix years, the prevalence of obesity is 22% for not-Hispanic blackness youth, 25.8% for Hispanic youth, 14.1% for non-Hispanic white youth, and 11% for Asian youth (28). Hispanic boys have the highest obesity rates (28%), followed by non-Hispance black girls (25.ane%) and Hispanic girls (23.6%) (28). The everyman obesity rates were plant in Asian youth. With regard to socieconomic condition, the inverse trends for lower obesity rates and college income and instruction (of households) held in all race and ethnic origin groups with the post-obit exceptions: obesity prevalence was lower in the highest income group only in Hispanic and Asian boys and did non differ by income among not-Hispanic black girls (42).

Figure 5

Prevalence of obesity amongst youth anile 2–19 years, by sex and race and Hispanic origin: United States, 2015–2016. Taken from reference (28).

Cardinal Obesity

As discussed above, central weight distribution occurs more than commonly in men than women and increases in both men and women with increasing historic period. In 1 of the few datasets that have published time-trends in waist circumference, it has been shown that over the past xx years, historic period-adapted waist circumferences take tracked upward in both US men and women (Figure 6). Much of this probable reflects the population increases in obesity prevelance since increasing fat mass and visceral fat track together (44).

Effigy 6

Historic period-adjusted mean waist circumference among adults in the National Health and Diet Test Survey 1999-2012. Adapted from (45).

Historically, international obesity rates have been lower than in the US and most developing countries considered undernutrition to be their topmost health priority (46). However, international rates of overweight and obesity take been ascent steadiy for the past several decades and, in many countries, are now meeting or exceeding those of the US (Effigy 7), (47, 48). In 2016, 1.3 billion adults were overweight worldwide and, between 1975 to 2016, the number of adults with obesity increased over six-fold, from 100 one thousand thousand to 671 million (69 to 390 million women, 31 to 281 million men ) (47). Specially worrisome have been similar trends in the youth around the world (Figure 7), from 5 million girls and 6 1000000 boys with obesity in 1975 to 50 meg girls and 74 meg boys in 2016 (47), as this means the rise in obesity rates will continue for decades as they mature into adults.

Figure 7

Trends in the number of adults, children, and adolescents with obesity and with moderate and severe underweight past region. Children and adolescents were aged 5–nineteen years. (47).

The growth in the wordwide prelance of overweight and obesity is thought to be primarily driven by economical and technological advancements in all developing societies aroung the globe (49, l). These forces have been ongoing in the US and other Western countries for many years but are being experienced past many developong countries on a compressed timescale. Greater worker productivity in advancing economies ways more time spent in sedentary piece of work (less in manual labor) and less fourth dimension spent in leisure activity. Greater wealth allows the buy of televisions, cars, processed foods, and more than meals eaten out of the house, all of which take been associated with greater rates of obesity in children and adults. More than details and greater discussion of these issues can exist found in EndoText Chapters on Non-excercisse Activity Thermogenesis (51)and Obesity and the Environment (52).

Regardless of the causes, these trends in global weight proceeds and obesity are quickly creating a tremendous brunt on health-care systems and cost to countries attempting to respond to the increased treatment demands(53). In addition, they are too feuling a ascent in global morbity and mortality for chronic (non-communicable) diseases, particularly for cardiovascular disease and type ii diabetes mellitus, and especially in Asian and Southward Asian populations where rates of blazon 2 diabetes are currently exploding (14, 54-57). Efforts need to be made deliver adequate wellness intendance to those in need and, at the same fourth dimension, find innovative and alternative solutions that allow economies to prosper and to incorporate technologies and then equally to reverse current trends in obesity and obesit-related diseases.

SUMMARY

The full general rise in obesity that has been occurring over the past 50 years in the US is now occurring globally. Women have college obesity rates than men, and in the U.s.a., minorities are unduly affected compared to not-Hispanic whites, including blacks, native Americans, and Hispanics. Especially worrisome are similar global trends in the increment in prevalence of obesity in children and adolescents as these groups will continue to contribute to a rising obesity rate in adults for several decades afterward. As important as finding solutions that accost the global logistical and financial challenges facing health-care systems attempting to encounter electric current demands of obesity-related co-morbidities will be finding innovative solutions that foreclose further weight gain within developing (and developed) countries.

REFERENCES

1. Kampe J, Tschop M, Horvath TL, Widmer P2010 Neuroendocrine Integration of Trunk Weight Regulation. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits Thousand, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A eds. Endotext. Southward Dartmouth (MA)

2. Kyrou I, Randeva HS, Weickert MO2018 Clinical Bug Caused by Obesity. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits Grand, McLachlan R, New M, Purnell J, Rebar R, Vocaliser F, Vinik A eds. Endotext. S Dartmouth (MA)

3. Farooqi IS, O'Rahilly S2017 The Genetics of Obesity in Humans. In: De Groot LJ, Chrousos G, Dungan Grand, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits One thousand, McLachlan R, New Thou, Purnell J, Rebar R, Vocaliser F, Vinik A eds. Endotext. South Dartmouth (MA)

4. O'Brien P2016 Surgical Treatment of Obesity. In: De Groot LJ, Chrousos G, Dungan Thou, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits 1000, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A eds. Endotext. South Dartmouth (MA)

5. Kim TY, Kim South, Schafer AL2018 Medical Management of the Postoperative Bariatric Surgery Patient. In: De Groot LJ, Chrousos M, Dungan Yard, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New Chiliad, Purnell J, Rebar R, Singer F, Vinik A eds. Endotext. South Dartmouth (MA)

6. Bray GA2016 Prevention of Obesity. In: De Groot LJ, Chrousos Chiliad, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits G, McLachlan R, New M, Purnell J, Rebar R, Vocalizer F, Vinik A eds. Endotext. Due south Dartmouth (MA)

7. Kumar RB, Aronne LJ2017 Pharmacologic Handling of Obesity. In: De Groot LJ, Chrousos G, Dungan Chiliad, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits 1000, McLachlan R, New 1000, Purnell J, Rebar R, Singer F, Vinik A eds. Endotext. South Dartmouth (MA)

8. DiPietro L, Stachenfeld NS2017 Exercise Treatment of Obesity. In: De Groot LJ, Chrousos M, Dungan M, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New One thousand, Purnell J, Rebar R, Vocaliser F, Vinik A eds. Endotext. South Dartmouth (MA)

9. Chadt A, Scherneck S, Joost HG, Al-Hasani H2018 Molecular links between Obesity and Diabetes: "Diabesity". In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New Yard, Purnell J, Rebar R, Vocaliser F, Vinik A eds. Endotext. South Dartmouth (MA)

10. Feingold KR, Grunfeld C2018 Obesity and Dyslipidemia. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits Thousand, McLachlan R, New M, Purnell J, Rebar R, Vocalizer F, Vinik A eds. Endotext. Southward Dartmouth (MA)

11. Westerterp KR2016 Control of Energy Expenditure in Humans. In: De Groot LJ, Chrousos Thou, Dungan One thousand, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits Chiliad, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A eds. Endotext. South Dartmouth (MA)

12. Myers MG, Leibel RL2015 Lessons From Rodent Models of Obesity. In: De Groot LJ, Chrousos G, Dungan M, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New Yard, Purnell J, Rebar R, Vocalist F, Vinik A eds. Endotext. South Dartmouth (MA)

13. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, tertiary, Moy CS, Muntner P, Mussolino ME, Nasir Yard, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C, Stroke Statistics South2016 Center Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Apportionment 133:e38-e360

14. Collaborators GBDO, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, Naghavi M, Salama JS, Vos T, Abate KH, Abbafati C, Ahmed MB, Al-Aly Z, Alkerwi A, Al-Raddadi R, Amare AT, Amberbir A, Amegah AK, Amini Due east, Amrock SM, Anjana RM, Arnlov J, Asayesh H, Banerjee A, Barac A, Baye E, Bennett DA, Beyene AS, Biadgilign Southward, Biryukov South, Bjertness E, Boneya DJ, Campos-Nonato I, Carrero JJ, Cecilio P, Cercy K, Ciobanu LG, Cornaby Fifty, Damtew SA, Dandona L, Dandona R, Dharmaratne SD, Duncan BB, Eshrati B, Esteghamati A, Feigin VL, Fernandes JC, Furst T, Gebrehiwot TT, Gold A, Gona PN, Goto A, Habtewold TD, Hadush KT, Hafezi-Nejad Due north, Hay SI, Horino M, Islami F, Kamal R, Kasaeian A, Katikireddi SV, Kengne AP, Kesavachandran CN, Khader YS, Khang YH, Khubchandani J, Kim D, Kim YJ, Kinfu Y, Kosen S, Ku T, Defo BK, Kumar GA, Larson HJ, Leinsalu M, Liang X, Lim SS, Liu P, Lopez AD, Lozano R, Majeed A, Malekzadeh R, Malta DC, Mazidi 1000, McAlinden C, McGarvey ST, Mengistu DT, Mensah GA, Mensink GBM, Mezgebe HB, Mirrakhimov EM, Mueller UO, Noubiap JJ, Obermeyer CM, Ogbo FA, Owolabi MO, Patton GC, Pourmalek F, Qorbani Thousand, Rafay A, Rai RK, Ranabhat CL, Reinig North, Safiri S, Salomon JA, Sanabria JR, Santos IS, Sartorius B, Sawhney One thousand, Schmidhuber J, Schutte AE, Schmidt MI, Sepanlou SG, Shamsizadeh 1000, Sheikhbahaei S, Shin MJ, Shiri R, Shiue I, Roba HS, Silva DAS, Silverberg JI, Singh JA, Stranges S, Swaminathan S, Tabares-Seisdedos R, Tadese F, Tedla BA, Tegegne BS, Terkawi AS, Thakur JS, Tonelli M, Topor-Madry R, Tyrovolas S, Ukwaja KN, Uthman OA, Vaezghasemi M, Vasankari T, Vlassov VV, Vollset SE, Weiderpass E, Werdecker A, Wesana J, Westerman R, Yano Y, Yonemoto N, Yonga M, Zaidi Z, Zenebe ZM, Zipkin B, Murray CJL2017 Health Furnishings of Overweight and Obesity in 195 Countries over 25 Years. North Engl J Med 377:xiii-27

15. Schenkeveld L, Magro K, Oemrawsingh RM, Lenzen Thousand, de Jaegere P, van Geuns RJ, Serruys Pow, van Domburg RT2012 The influence of optimal medical handling on the 'obesity paradox', body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective accomplice study. BMJ Open two:e000535

16. Jackson Equally, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, Skinner JS, Bouchard C, Wilmore JH2002 The effect of sexual practice, age and race on estimating percentage body fat from body mass index: The Heritage Family unit Study. Int J Obes Relat Metab Disord 26:789-796

17. Jackson Every bit, Ellis KJ, McFarlin BK, Sailors MH, Bray MS2009 Body mass index bias in defining obesity of various young adults: the Training Intervention and Genetics of Practice Response (TIGER) study. Br J Nutr 102:1084-1090

18. Najjar MF, Rowland G1987 Anthropometric reference data and prevalence of overweight, United States, 1976-fourscore. Vital Health Stat 11:1-73

19. 1998 Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Testify Study. National Institutes of Health. Obes Res 6 Suppl 2:51S-209S

20. Consultation WHOE2004 Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157-163

21. Janssen I, Katzmarzyk PT, Ross R2004 Waist circumference and not body mass alphabetize explains obesity-related health risk. Am J Clin Nutr 79:379-384

22. Balkau B, Deanfield JE, Despres JP, Bassand JP, Fox KA, Smith SC, Jr., Barter P, Tan CE, Van Gaal Fifty, Wittchen HU, Massien C, Haffner SM2007 International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 master care patients in 63 countries. Circulation 116:1942-1951

23. Grundy SM2005 Metabolic syndrome scientific statement past the American Middle Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol 25:2243-2244

24. Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP, Brown WV2015 National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full written report. Journal of clinical lipidology nine:129-169

25. Fujimoto WY, Bergstrom RW, Boyko EJ, Leonetti DL, Newell-Morris LL, Wahl Prisoner of war1995 Susceptibility to development of fundamental adiposity among populations. Obes Res three Suppl two:179S-186S

26. Alberti KG, Zimmet P, Shaw J2006 Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic medicine : a periodical of the British Diabetic Clan 23:469-480

27. 2008 Waist circumference and waist–hip ratio: report of a WHO expert consultation. In. Geneva, Switzerland: Globe Health Organization; 1-39

28. Hales CM, Carroll Md, Fryar CD, Ogden CL2017 Prevalence of Obesity Among Adults and Youth: United States, 2015-2016. NCHS data brief:ane-8

29. Friedman JM2003 A war on obesity, not the obese. Science 299:856-858

30. Prentice AM1997 Obesity--the inevitable punishment of civilisation? Br Med Bull 53:229-237

31. Fryar CD, Carroll Medico, Ogden CLPrevalence of Overweight, Obesity, and Extreme Obesity Among Adults Anile 20 and Over: United States, 1960–1962 Through 2013–2014. In: National Center for Health Statistics

32. Mott JW, Wang J, Thornton JC, Allison DB, Heymsfield SB, Pierson RN, Jr.1999 Relation betwixt body fat and historic period in 4 ethnic groups. Am J Clin Nutr 69:1007-1013

33. Gallagher D, Ruts E, Visser Thou, Heshka S, Baumgartner RN, Wang J, Pierson RN, Pi-Sunyer FX, Heymsfield SB2000 Weight stability masks sarcopenia in elderly men and women. Am J Physiol Endocrinol Metab 279:E366-375

34. Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA2002 Longitudinal changes in body limerick in older men and women: role of body weight alter and physical action. Am J Clin Nutr 76:473-481

35. Ley CJ, Lees B, Stevenson JC1992 Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 55:950-954

36. Svendsen OL, Hassager C, Christiansen C1995 Age- and menopause-associated variations in body limerick and fat distribution in healthy women every bit measured by dual-energy X-ray absorptiometry. Metabolism 44:369-373.

37. Panotopooulos 1000, Ruiz JC, Raison J, Guygrand B, Basdevant B, Basdevant A1996 Menopause, fat and lean distribution in obese women. Maturitas 25:xi-nineteen

38. Ogden CL, Fakhouri Th, Carroll MD, Hales CM, Fryar CD, Li X, Freedman DS2017 Prevalence of Obesity Amongst Adults, by Household Income and Didactics - United States, 2011-2014. MMWR Morb Mortal Wkly Rep 66:1369-1373

39. Singh Every bit, Mulder C, Twisk JW, van Mechelen Westward, Chinapaw MJ2008 Tracking of babyhood overweight into machismo: a systematic review of the literature. Obes Rev ix:474-488

40. Rosenbaum Thousand2013 Special Considerations Relative to Pediatric Obesity. In: De Groot LJ, Chrousos G, Dungan One thousand, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits Grand, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A eds. Endotext. South Dartmouth (MA)

41. Buscot MJ, Thomson RJ, Juonala Chiliad, Sabin MA, Burgner DP, Lehtimaki T, Hutri-Kahonen Northward, Viikari JSA, Jokinen E, Tossavainen P, Laitinen T, Raitakari OT, Magnussen CG2018 BMI Trajectories Associated With Resolution of Elevated Youth BMI and Incident Developed Obesity. Pediatrics 141

42. Ogden CL, Carroll MD, Fakhouri TH, Hales CM, Fryar CD, Li X, Freedman DS2018 Prevalence of Obesity Among Youths by Household Income and Education Level of Head of Household - Usa 2011-2014. MMWR Morb Mortal Wkly Rep 67:186-189

43. Summary Wellness Statistics Tables: National Health Interview Survey.Tabular array A-15. Body mass index among adults aged 18 and over, by selected characteristics: The states, 2016. In. 2016 ed: National Center for Health Statistics

44. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despres JP1993 Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 58:463-467

45. Ford ES, Maynard LM, Li C2014 Trends in mean waist circumference and abdominal obesity among US adults, 1999-2012. JAMA 312:1151-1153

46. York DA, Rossner S, Caterson I, Chen CM, James WP, Kumanyika South, Martorell R, Vorster HH, American Heart A2004 Prevention Conference VII: Obesity, a worldwide epidemic related to middle disease and stroke: Grouping I: worldwide demographics of obesity. Circulation 110:e463-470

47. Collaboration NCDRF2017 Worldwide trends in torso-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390:2627-2642

48. Finucane MM, Stevens GA, Cowan MJ, Danaei M, Lin JK, Paciorek CJ, Singh GM, Gutierrez 60 minutes, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati Yard, Global Burden of Metabolic Take a chance Factors of Chronic Diseases Collaborating One thousand2011 National, regional, and global trends in torso-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 1000000 participants. Lancet 377:557-567

49. Popkin BM, Horton Due south, Kim Due south, Mahal A, Shuigao J2001 Trends in diet, nutritional condition, and nutrition-related noncommunicable diseases in Cathay and India: the economic costs of the nutrition transition. Nutr Rev 59:379-390

50. Levine JA, Kotz CM2005 Cracking--non-exercise activity thermogenesis--egoistic & geocentric environmental factors vs. biological regulation. Acta Physiol Scand 184:309-318

51. von Loeffelholz C2014 The Function of Not-exercise Activity Thermogenesis in Human Obesity. In: De Groot LJ, Chrousos Thousand, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits Chiliad, McLachlan R, New M, Purnell J, Rebar R, Vocalizer F, Vinik A eds. Endotext. Southward Dartmouth (MA)

52. Brehm BJ, D'Alessio DA2014 Environmental Factors Influencing Obesity. In: De Groot LJ, Chrousos Grand, Dungan Chiliad, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New Thousand, Purnell J, Rebar R, Singer F, Vinik A eds. Endotext. South Dartmouth (MA)

53. Withrow D, Alter DA2011 The economic burden of obesity worldwide: a systematic review of the straight costs of obesity. Obes Rev 12:131-141

54. Bragg F, Tang Thousand, Guo Y, Iona A, Du H, Holmes MV, Bian Z, Kartsonaki C, Chen Y, Yang L, Sun Q, Dong C, Chen J, Collins R, Peto R, Li Fifty, Chen Z, China Kadoorie Biobank Collaborative G2018 Associations of Full general and Central Adiposity With Incident Diabetes in Chinese Men and Women. Diabetes Care 41:494-502

55. Tirosh A, Shai I, Afek A, Dubnov-Raz G, Ayalon N, Gordon B, Derazne E, Tzur D, Shamis A, Vinker Due south, Rudich A2011 Adolescent BMI trajectory and take a chance of diabetes versus coronary disease. N Engl J Med 364:1315-1325

56. Global BMIMC, Di Angelantonio E, Bhupathiraju Sh N, Wormser D, Gao P, Kaptoge S, Berrington de Gonzalez A, Cairns BJ, Huxley R, Jackson Ch L, Joshy G, Lewington S, Manson JE, Spud N, Patel AV, Samet JM, Woodward Thou, Zheng W, Zhou M, Bansal N, Barricarte A, Carter B, Cerhan JR, Smith GD, Fang X, Franco OH, Green J, Halsey J, Hildebrand JS, Jung KJ, Korda RJ, McLerran DF, Moore SC, O'Keeffe LM, Paige E, Ramond A, Reeves GK, Rolland B, Sacerdote C, Sattar Due north, Sofianopoulou Eastward, Stevens J, Thun M, Ueshima H, Yang L, Yun YD, Willeit P, Banks E, Beral Five, Chen Z, Gapstur SM, Gunter MJ, Hartge P, Jee SH, Lam TH, Peto R, Potter JD, Willett WC, Thompson SG, Danesh J, Hu FB2016 Torso-mass alphabetize and all-cause bloodshed: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 388:776-786

57. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, Cavan D, Shaw JE, Makaroff LE2017 IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice 128:40-l

holbrookpeatchath.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/books/NBK279167/

Share this post